LungVision AI-Augmented Fluoroscopic Navigation for Intraoperative Pulmonary Nodule Localization
NCT: NCT07682012 · COMPLETED
Brief Summary
This prospective single-center pilot study evaluates the clinical feasibility, localization accuracy, and safety of the LungVision system-an AI-augmented fluoroscopic navigation platform-for real-time intraoperative localization of small pulmonary nodules during video-assisted thoracoscopic surgery (VATS). All enrolled patients underwent dual localization: preoperative marking via CT-guided dye injection or virtual bronchoscopic navigation (Broncus Archimedes), followed by intraoperative localization using the LungVision system. The primary outcome was localization success rate, defined as the proportion of patients achieving fluoroscopic tool-in-lesion confirmation. Secondary outcomes included complete resection rate, navigation time, total operative time, and perioperative complication rate.
Frequently Asked Questions
What is LungVision AI-Augmented Fluoroscopic Navigation for Intraoperative Pulmonary Nodule Localization?
LungVision AI-Augmented Fluoroscopic Navigation for Intraoperative Pulmonary Nodule Localization is a clinical trial registered under NCT07682012. Current status: COMPLETED.
What is the status of NCT07682012?
The current status of NCT07682012 (LungVision AI-Augmented Fluoroscopic Navigation for Intraoperative Pulmonary Nodule Localization) is: COMPLETED.
When did LungVision AI-Augmented Fluoroscopic Navigation for Intraoperative Pulmonary Nodule Localization start?
LungVision AI-Augmented Fluoroscopic Navigation for Intraoperative Pulmonary Nodule Localization started on 2024-01-01.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.